Showing results (81-90 of 102) with videos related to
Sort By:
Pageof 11
Asia-Pacific Journal of Clinical Oncology|February 15, 2019
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survivalShehara Mendis, Sophie Beck, Belinda Lee, et al.Pharmacoeconomics|August 18, 2020
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry DataKoen Degeling, Hui-Li Wong, Hendrik Koffijberg, et al.JCO Oncology Practice|May 14, 2020
Practical Considerations for Treating Patients With Cancer in the COVID-19 PandemicEva Segelov, Craig Underhill, Hans Prenen, et al.Journal of Geriatric Oncology|March 28, 2015
Geriatric assessment of older patients with cancer in Australia--a multicentre auditRoopa Lakhanpal, Jaclyn Yoong, Sachin Joshi, et al.Seminars in Oncology Nursing|August 30, 2024
"Pioneers, yes. We all should think that way" Improving Papua New Guinea Cancer Nurses Education through an International PartnershipCatherine Paterson, Merilyn Nicholas, Peter Fore, et al.Asia-Pacific Journal of Clinical Oncology|March 17, 2017
How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?Lewis Au, Natalie Turner, Hui-Li Wong, et al.Asia-Pacific Journal of Clinical Oncology|April 19, 2021
Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian populationSandy Tun Min, Aflah Roohullah, Annette Tognela, et al.Clinical Colorectal Cancer|September 13, 2020
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance StatusAvraham Travers, Azim Jalali, Stephen Begbie, et al.Frontiers in Immunology|July 3, 2020
Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES SwitchWen Juan Tu, Robert D McCuaig, Abel H Y Tan, et al.Asia-Pacific Journal of Clinical Oncology|November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort studyBelinda Lee, Hui-Li Wong, Mark Tacey, et al.Pageof 11